AnneMWallaceMD
General Surgery • San Diego, CABreast, Melanoma, Surgical Oncology (Other than Breast)
Professor of Clinical Surgery, UC San Diego // Director, Comprehensive Breast Health Center at Moores Cancer Center
Dr. Wallace is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 W Arbor Dr
San Diego, CA 92103Phone+1 858-822-6193Fax+1 858-822-6194
Summary
- I am board certified in general surgery and plastic surgery and specialize in breast health, focusing on breast cancer and breast reconstruction. I also have experience in all forms of cosmetic breast and body-contouring surgery. My research focuses on developing better imaging technology to detect breast cancer and melanoma.
Education & Training
University of California (San Diego) Medical CenterResidency, Plastic Surgery - Integrated, 1992 - 1994
MedStar Health/Georgetown-Washington HospitalResidency, Surgery, 1987 - 1992
Creighton University School of MedicineClass of 1987
Certifications & Licensure
CA State Medical License 1991 - 2025
MA State Medical License 2014 - 2025
TX State Medical License 1994 - 1996- American Board of Plastic Surgery Plastic Surgery
- American Board of Surgery Surgery
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
- Super Doctor SuperDoctors.com
Clinical Trials
- Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy Start of enrollment: 2008 Nov 10
- I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer Start of enrollment: 2010 Mar 01
Publications & Presentations
PubMed
- 40 citationsNeoadjuvant T-DM1/pertuzumab and paclitaxel/trastuzumab/pertuzumab for HER2+ breast cancer in the adaptively randomized I-SPY2 trial.Amy S. Clark, Christina Yau, Denise M. Wolf, Emanuel F. Petricoin, Laura J. van't Veer
Nature Communications. 2021-11-05 - 424 citationsEffect of Pembrolizumab Plus Neoadjuvant Chemotherapy on Pathologic Complete Response in Women With Early-Stage Breast Cancer: An Analysis of the Ongoing Phase 2 Adapt...Rita Nanda, Minetta C. Liu, Christina Yau, Rebecca Shatsky, Lajos Pusztai
JAMA Oncology. 2020-05-01 - 16 citationsGanitumab and metformin plus standard neoadjuvant therapy in stage 2/3 breast cancerDouglas Yee, Claudine Isaacs, Denise M. Wolf, Christina Yau, Paul Haluska
NPJ Breast Cancer. 2021-10-05
Press Mentions
Could an EHR Nudge Reduce Unnecessary Biopsies?July 18th, 2024- Breast Cancer Rate Rises in Women Under 40: What We Can DoFebruary 22nd, 2021
- San Diego’s Top Doctors 2020: The ListOctober 28th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
